Amnestic mild cognitive impairment in Parkinson's disease: White matter structural changes and mechanisms

Fuyong Chen1,2,3, Tao Wu4,5, Yuejia Luo6,7

  • 1Department of Neurosurgery, Shenzhen University General Hospital, Shenzhen University, Shenzhen, Guangdong Province, China.

Plos One
|December 13, 2019
PubMed

Insights

Mild cognitive impairment in Parkinson's disease (PD-aMCI) shows white matter changes related to memory, not just motor symptoms. These structural differences suggest a common dopaminergic pathway impacting both cognition and movement.

Area of Science:

  • Neuroscience
  • Neurology
  • Radiology

Background:

  • Mild cognitive impairment (MCI) is common in Parkinson's disease (PD), with the amnestic subtype (PD-aMCI) posing a higher dementia risk.
  • White matter (WM) structural changes in PD-aMCI are understudied.
  • Understanding WM alterations is crucial for differentiating PD subtypes and predicting dementia progression.

Purpose of the Study:

  • To investigate and characterize white matter (WM) structural differences in patients with amnestic mild cognitive impairment due to Parkinson's disease (PD-aMCI).
  • To differentiate WM changes related to cognitive impairment from those associated with motor deficits in PD.
  • To explore the relationship between WM integrity and memory function in PD patients.

Main Methods:

  • Utilized voxel-based and tract-based spatial statistics (TBSS) on diffusion tensor imaging (DTI) metrics (FA, AD, RD).
  • Compared PD-aMCI (n=17) with cognitively normal PD (PD-CN, n=19) and healthy controls (n=20).
  • Analyzed WM changes with and without motor performance as a covariate, and correlated WM measures with memory performance.

Main Results:

  • PD-aMCI patients exhibited reduced fractional anisotropy (FA) in diffuse WM areas compared to PD-CN.
  • PD-CN showed increased axial diffusivity (AD) and radial diffusivity (RD) in the right caudate compared to controls.
  • Motor adjustment attenuated most FA differences between PD-aMCI and PD-CN, which largely overlapped with memory-correlated FA values.

Conclusions:

  • White matter structural differences in PD-aMCI are primarily linked to memory impairment.
  • The influence of motor adjustment suggests a shared neuropathological mechanism, potentially dopaminergic, underlying both motor and cognitive deficits in PD-aMCI.
  • Findings highlight the importance of considering cognitive-specific WM changes in PD progression and management.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
890
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
463
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
709